LOGIN  |  REGISTER
Cue Biopharma

Nanalysis Scientific (TSX.V: NSCI) Stock Quote

Last Trade: C$0.41
Volume: 98,757
5-Day Change: 3.80%
YTD Change: 9.33%
Market Cap: C$41.570M

Latest News From Nanalysis Scientific

CALGARY, AB , March 20, 2024 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (the " Company " or " Nanalysis ") is pleased to announce that it has closed its prospectus exempt offering of units (the " Offering ") and concurrent brokered "best efforts" prospectus exempt offering of units (the " Concurrent Offering" ), as announced on March 6, 2024 . A total of 11,111,110 units (the " Units ") were issued at a price of $0.45... Read More
CALGARY, AB , March 6, 2024 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (the " Company " or " Nanalysis Scientific ") is pleased to announce a best efforts prospectus exempt offering (the " Offering ") of up to 11,111,111 units (the " Units ") of the Company at a price of $0.45 per Unit (the " Issue Price ") for gross proceeds of up to $5,000,000 , pursuant to the listed issuer financing exemption available under Part 5A... Read More
CALGARY, AB , Feb. 7, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference. Event: Radius Research Pitch, Deep Dive, and Q&A with Nanalysis... Read More
CALGARY, AB , Feb. 6, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments. Sean Krakiwsky , Founder and CEO of Nanalysis , states: "We are... Read More
Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11 , 2024 CALGARY, AB , Jan. 30, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, gives an update on its subsidiary K'(Prime) Technologies ("KPrime") security... Read More
CALGARY, AB , Jan. 3, 2024 /CNW/ - Nanalysis Scientific Corp. ( TSXV:NSCI , OTCQX:NSCIF, FRA:1N1 ) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 475,000 Restricted Share Units ("RSU"s) to its independent Directors, pursuant to the Company's RSU plan. Each RSU is exercisable for one common share in the capital of the Company for a period ending at the end of the calendar year,... Read More
CALGARY, AB , Nov. 29, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30, 2023. Chief Executive Officer, Sean Krakiwsky, and Chief Financial Officer, Randall McRae, will host a conference call at 5 P.M. Eastern Time today to discuss... Read More
Hosting Call at 5:00 pm ET on Wednesday, November 29th European Q&A Session on November 30th at 8:30am ET CALGARY, AB , Nov. 15, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Wednesday, November 29th, 2023, the Company will put out a press release and Chief Executive... Read More
Chimerix

COPYRIGHT ©2023 HEALTH STOCKS HUB